# Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

> **NCT06765265** · PHASE4 · RECRUITING · sponsor: **King Edward Medical University** · enrollment: 152 (estimated)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DRUG:** Rosuvastatin 20 mg/day
- **DRUG:** Atorvastatin 40 mg

## Key facts

- **NCT ID:** NCT06765265
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-05
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06765265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06765265, "Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06765265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*